Medical research
Biodegradable gel boosts immune system's attack on several cancers in mice
A new biodegradable gel improves the immune system's ability to keep cancer at bay after tumors are surgically removed.
Apr 6, 2022
0
76
Page 34 - News tagged with tumor growth
Oncology & Cancer
Researchers identify an immunotherapy target to combat glioblastomas
Houston Methodist researchers have identified the genetic and molecular fingerprints of different cancer and immune cells in glioblastoma, the deadliest and most common type of brain cancer in adults.
Apr 5, 2022
0
39
Oncology & Cancer
Omega-3s could boost immunotherapy's cancer-fighting power
Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body's own immune system ...
Apr 1, 2022
0
17
Oncology & Cancer
New gene targets for treating adult blood cancer
Hokkaido University scientists have identified new targets for treating an aggressive form of adult leukemia with existing drugs. The findings were published in the journal Blood.
Mar 31, 2022
0
81
Oncology & Cancer
Spinal fluid sampling used to track treatment response in pediatric glioma
Treatment for glioma has long relied on MRI imaging to track tumor markers and treatment response. But findings from a team at the University of Michigan Rogel Cancer Center, led by Carl Koschmann, M.D., pediatric neuro-oncologist ...
Mar 24, 2022
0
30
Oncology & Cancer
Cancer cells found to replace depleted tryptophan using phenylalanine substitutants
An international team of researchers has found that some cancer cells are able to make up for a loss of tryptophan by conducting codon reassignments that allow for the production of phenylalanine "substitutants" (a word they ...
Oncology & Cancer
Drug combination shows effectiveness in patients with recurrent ER-positive endometrial cancer
A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from ...
Mar 20, 2022
0
94
Oncology & Cancer
A potential new target for cancer immunotherapies
Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine and Albert ...
Mar 16, 2022
0
57
Medications
Treating tough tumors by exploiting their iron 'addiction'
Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account ...
Mar 9, 2022
0
5
Oncology & Cancer
A new approach for bolstering the ability of T cells to fight cancer
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer therapy.
Mar 8, 2022
1
111
